3. Umbruch 4.4..2005 - Online Pot

Potential use of cannabimimetics in the treatment of cancer 177
15 Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor
for cannabinoids. Nature 365: 61–65
16 Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994)
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature
372: 686–691
17 Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello
A, Paul P, Williams EJ et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and
temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463–468
18 Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997) Accumulation of N-arachidonoylethanolamine
(anandamide) into cerebellar granule cells occurs via facilitated diffusion. J
Neurochem 69: 631–638
19 Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular characterization
of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83–87
20 Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C (1997) cDNA cloning, tissue distribution,
and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship
to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 272: 27218–27223
21 Howlett AC (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:
607–634
22 Piomelli D (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4:
873–884
23 Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296: 678–682
24 Guzman M, Sanchez C, Galve-Roperh I (2001) Control of the cell survival/death decision by
cannabinoids. J Mol Med 78: 613–625
25 Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, Dubinett SM (2000)
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB 2 receptor-mediated,
cytokine-dependent pathway. J Immunol 165: 373–380
26 Hart S, Fischer OM, Ullrich A (2004) Cannabinoids induce cancer cell proliferation via tumor
necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal
growth factor receptor. Cancer Res 64: 1943–1950
27 Sanchez MG, Sanchez AM, Ruiz-Llorente L, Diaz-Laviada I (2003) Enhancement of androgen
receptor expression induced by R-methanandamide in prostate LNCaP cells. FEBS Lett 555:
561–566
28 Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA (1975) Antineoplastic activity
of cannabinoids. J Natl Cancer Inst 55: 597–602
29 (1996) Toxicology and carcinogenesis studies of 1-trans-delta-9-tetrahydrocannabinol in
F344N/N rats and BC63F1 mice. National Institutes of Health National Toxicology Program,NIH
Publication No. 97–3362
30 De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (1998)
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc
Natl Acad Sci USA 95: 8375–8380
31 Melck D, Rueda D, Galve-Roperh I, De Petrocellis L, Guzman M, Di Marzo V (1999)
Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the
anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett 463: 235–240
32 Melck D, De Petrocellis L, Orlando P, Bisogno T, Laezza C, Bifulco M, Di Marzo V (2000)
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids
leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141:
118–126
33 Bifulco M, Laezza C, Portella G, Vitale M, Orlando P, De Petrocellis L, Di Marzo V (2001)
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB
J 15: 2745–2747
34 Rueda D, Navarro B, Martinez-Serrano A, Guzman M, Galve-Roperh I (2002) The endocannabinoid
anandamide inhibits neuronal progenitor cell differentiation through attenuation of the
Rap1/B-Raf/ERK pathway. J Biol Chem 277: 46645–46650
35 Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman
JW, Jorcano JL, Guzman M (2003) Inhibition of skin tumor growth and angiogenesis in vivo by
activation of cannabinoid receptors. J Clin Invest 111: 43–50
36 Mimeault M, Pommery N, Wattez N, Bailly C, Henichart JP (2003) Anti-proliferative and apoptotic
effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth